Baijiayun Was Awarded the "2024 Future Medical Technology Leader" and Gained Another Industry Recognition

Rhea-AI Summary

Baijiayun Group (NASDAQ: RTC), an AI video solution provider, was awarded the '2024 Future Medical Technology Leader' at a conference in Beijing. CEO Yi Ma delivered a speech about AI and audio-video technology in healthcare. The company provided live streaming support for the conference, reaching over 100,000 views.

Baijiayun has been supporting medical industry digitalization through various services including medical live broadcasts, online seminars, remote consultations, live surgeries, and online training. The company has served dozens of medical clients, enabling remote learning for intern doctors and improving access to medical training in remote areas.

Positive

• Live streaming conference support reached over 100,000 views
• Received industry recognition with '2024 Future Medical Technology Leader' award
• Established presence in medical sector with multiple service offerings
• Serving dozens of medical-related clients

Negative

• None.

BEIJING, Nov. 14, 2024 /PRNewswire/ -- Baijiayun Group Ltd ("Baijiayun" or the "Company") (NASDAQ: RTC), a one-stop AI video solution provider, today announced it was awarded the "2024 Future Medical Technology Leader".

The 2024 Future Medical Technology Conference was grandly held in Beijing. As a leading audio and video technology enterprise in the domestic AI medical field for many years, Mr. Yi Ma, the CEO of Baijiayun Group, was invited to attend this conference. He delivered a speech of "AI + Audio and Video Technology Helps the Medical and Health Industry Open Up a New Pattern" and participated in the round-table dialogue activity. Together with other attending guests present at the conference, he delved deeply into the practical application and implementation of AI technology in the medical field. Baijiayun provided exclusive live streaming support for this conference, with the number of viewings exceeding 100,000.

Over the past few years, Baijiayun has helped the medical industry achieve digital transformation and upgrading through forms such as medical live broadcasts, online seminars, medical lectures, remote consultations, live surgeries, conference support, and online training. For example, Baijiayun has made it a reality to watch online medical live broadcasts anytime and anywhere, facilitating intern doctors to learn remotely and closely, and enabling intern medical staff to clearly see every part of the surgical site. Meanwhile, it has linked remote seminars and training sessions, realizing the sharing of renowned doctor resources, facilitating learning and communication among medical staff, saving learning costs, improving work efficiency, and effectively promoting the development of medical training in remote areas.

With its excellent technology and solid services, Baijiayun has served dozens of medical-related clients. It has accumulated rich experience through long-term practice and continuous refinement.

The host of the conference fully affirmed Baijiayun's outstanding contributions to the field of AI in medical care, and awarded Baijiayun the honor of "2024 Future Medical Technology Leader". The strength of Baijiayun's AI audio and video technology has once again gained recognition by the industry.

About Baijiayun Group Ltd 

Baijiayun is a one-stop AI video solution provider with core expertise in SaaS/PaaS solutions. Baijiayun is committed to delivering reliable, high-quality video experiences across devices and localities and has grown rapidly since its inception in 2017. Premised on its industry-leading video-centric technologies, Baijiayun offers a wealth of video-centric technology solutions, including Video SaaS/PaaS, Video Cloud and Software, and Video AI and System Solutions. Baijiayun caters to the evolving communications and collaboration needs of enterprises of all sizes and industries. For more information, please visit ir.baijiayun.com.

Safe Harbor Statement

This press release contains certain "forward-looking statements." These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the parties' perspectives and expectations, are forward-looking statements. The words "will," "expect," "believe," "estimate," "intend," and "plan" and similar expressions indicate forward-looking statements.

Such forward-looking statements are inherently uncertain, and shareholders and other potential investors must recognize that actual results may differ materially from the expectations as a result of a variety of factors. Such forward-looking statements are based upon management's current expectations and include known and unknown risks, uncertainties, and other factors, many of which are hard to predict or control, that may cause the actual results, performance, or plans to differ materially from any future results, performance or plans expressed or implied by such forward-looking statements. The forward-looking information provided herein represents the Company's estimates as of the date of this press release, and subsequent events and developments may cause the Company's estimates to change.

The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.

A further list and description of risks and uncertainties can be found in the documents the Company has filed or furnished or may file or furnish with the U.S. Securities and Exchange Commission, which you are encouraged to read. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements. Forward-looking statements relate only to the date they were made, and the Company undertakes no obligation to update forward-looking statements to reflect events or circumstances after the date they were made except as required by law or applicable regulation.

For investor and media enquiries, please contact:

Company Contact:
Ms. Fangfei Liu 
Chief Financial Officer, Baijiayun Group Ltd
Phone: +86 25 8222 1596
Email: ir@baijiayun.com

View original content:https://www.prnewswire.com/news-releases/baijiayun-was-awarded-the-2024-future-medical-technology-leader-and-gained-another-industry-recognition-302305625.html

SOURCE Baijiayun Group Ltd

FAQ

What award did Baijiayun (RTC) receive at the 2024 Future Medical Technology Conference?

Baijiayun (RTC) was awarded the '2024 Future Medical Technology Leader' at the Future Medical Technology Conference in Beijing.

How many views did Baijiayun's (RTC) live streaming support achieve at the medical technology conference?

Baijiayun's live streaming support for the conference exceeded 100,000 views.

What medical services does Baijiayun (RTC) provide through its technology?

Baijiayun provides medical live broadcasts, online seminars, medical lectures, remote consultations, live surgeries, conference support, and online training services.